Phosphatidylinositol 4-kinase IIIβ regulates the transport of ceramide between the endoplasmic reticulum and Golgi

The recently identified ceramide transfer protein, CERT, is responsible for the bulk of ceramide transport from the endoplasmic reticulum ( ER) to the Golgi. CERT has a C-terminal START domain for ceramide binding and an N-terminal pleckstrin homology domain that binds phosphatidylinositol 4-phosphate suggesting that phosphatidylinositol ( PI) 4-kinases are involved in the regulation of CERT-mediated ceramide transport. In the present study fluorescent analogues were used to follow the ER to Golgi transport of ceramide to determine which of the four mammalian PI 4-kinases are involved in this process. Overexpression of pleckstrin homology domains that bind phosphatidylinositol 4-phosphate strongly inhibited the transport of C5-BODIPY-ceramide to the Golgi. A newly identified PI3-kinase inhibitor, PIK93 that selectively inhibits the type III PI4-kinase beta enzyme, and small interfering RNA-mediated down-regulation of the individual PI4-kinase enzymes, revealed that PI4-kinase beta has a dominant role in ceramide transport between the ER and Golgi. Accordingly, inhibition of PI4-kinase III beta either by wortmannin or PIK93 inhibited the conversion of [H-3] serine-labeled endogenous ceramide to sphingomyelin. Therefore, PI4-kinase beta is a key enzyme in the control of spingomyelin synthesis by controlling the flow of ceramide from the ER to the Golgi compartment.